Administration of protamine after coronary stent deployment
- 1 July 1999
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 138 (1) , 64-68
- https://doi.org/10.1016/s0002-8703(99)70248-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)Journal of the American College of Cardiology, 1995
- Protamine induces endothelium-dependent vasodilatation of the pulmonary arteryThe Annals of Thoracic Surgery, 1995
- Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound GuidanceCirculation, 1995
- Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.Circulation, 1994
- Peripheral vascular complications of directional coronary atherectomy and stenting: Predictors, management, and outcomeThe American Journal of Cardiology, 1994
- Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observationsCatheterization and Cardiovascular Diagnosis, 1994
- Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).Circulation, 1988
- Anticoagulation with heparin during cardiac catheterization and its reversal by protamineCatheterization and Cardiovascular Diagnosis, 1987
- ProtamineAnesthesia & Analgesia, 1985